Concerns About Disclosing a High-risk Cervical Human Papillomavirus (HPV) Infection to a Sexual Partner: a Systematic Review and Thematic Synthesis

Overview

Journal BMJ Sex Reprod Health

Specialties Health Services
Reproductive Medicine

Date 2020 Jan 10

PMID 31915190

Citations 12

Authors

Kirsty F Bennett

Jo Waller

Mairead Ryan

Julia V Bailey

Laura A V Marlow

Affiliations

Soon will be listed here.

Abstract

Background: Human papillomavirus (HPV)-based cervical screening is now replacing cytology-based screening in several countries and many women in screening programmes will consequently receive HPV-positive results. Because of the sexually transmitted nature of HPV, receiving an HPV-positive result may raise questions about disclosing the infection to a sexual partner.

Objective: To review the quantitative and qualitative literature exploring women's concerns about disclosing a high-risk cervical HPV infection to a sexual partner.

Methods: We searched MEDLINE, PsycINFO, CINAHL Plus, Web of Science and EMBASE for studies reporting at least one disclosure-related outcome among women with high-risk HPV. We also searched the grey literature and carried out forward/backward citation searches. A narrative synthesis for quantitative studies and a thematic synthesis for qualitative studies were conducted.

Results: Thirteen articles met the inclusion criteria (12 qualitative, 1 quantitative). In the quantitative study, 60% of HPV-positive women felt disclosing an HPV result was 'risky'. Concerns about disclosing HPV to a sexual partner were influenced by the stigma that is associated with having an STI and uncertainty about how their partner would respond. Women questioned how, when and to whom they should disclose their HPV-positive status.

Conclusions: The studies included in this review provide rich information about the range of concerns women have, the reasons for these concerns, and the questions women have about disclosing HPV to sexual partners. As studies were predominantly qualitative, the prevalence of concerns is unclear.

Citing Articles

A comparison of the persuasiveness of human and ChatGPT generated pro-vaccine messages for HPV.

Xia D, Song M, Zhu T Front Public Health. 2025; 12:1515871.

PMID: 39886390 PMC: 11780328. DOI: 10.3389/fpubh.2024.1515871.

Analysis of risk factors associated with cervical HPV infection and their effects on female sexual function and anxiety: a multicenter cross-sectional study based on Chinese women.

Wang H, Nie K, Liu Z, Zhao Y, Ha Y, Zhang H Front Oncol. 2024; 14:1468160.

PMID: 39512769 PMC: 11540700. DOI: 10.3389/fonc.2024.1468160.

On the path toward cervical cancer elimination in Canada: a national survey of factors influencing women's intentions to participate in human papillomavirus test-based primary cervical screening.

Tatar O, Haward B, Perez S, Zhu P, Brotherton J, Decker K Lancet Reg Health Am. 2024; 39:100901.

PMID: 39493836 PMC: 11530915. DOI: 10.1016/j.lana.2024.100901.

Unpacking HPV Stigma: Assessing Healthcare Workers' Knowledge and Stigma Towards HPV While Exploring the Connection Between the Two.

Ziaee A, Ziaee M, Asghari A, Elhamirad S, Azarkar G J Med Educ Curric Dev. 2024; 11:23821205241260596.

PMID: 38846082 PMC: 11155363. DOI: 10.1177/23821205241260596.

"There is nothing that can prevent me from supporting her:" men's perspectives on their involvement and support of women's use of topical therapy for cervical precancer treatment in Kenya.

Mungo C, Adewumi K, Adoyo E, Zulu G, Goraya S, Ogollah C Front Oncol. 2024; 14:1360337.

PMID: 38532929 PMC: 10964769. DOI: 10.3389/fonc.2024.1360337.

References

Newton D, McCabe M . Sexually transmitted infections: impact on individuals and their relationships. J Health Psychol. 2008; 13(7):864-9. DOI: 10.1177/1359105308095058. View

Cuzick J, Clavel C, Petry K, Meijer C, Hoyer H, Ratnam S . Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006; 119(5):1095-101. DOI: 10.1002/ijc.21955. View

Bosch F, Lorincz A, Munoz N, Meijer C, Shah K . The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002; 55(4):244-65. PMC: 1769629. DOI: 10.1136/jcp.55.4.244. View

Ebell M, Thai T, Royalty K . Cancer screening recommendations: an international comparison of high income countries. Public Health Rev. 2018; 39:7. PMC: 5833039. DOI: 10.1186/s40985-018-0080-0. View

Kosenko K, Hurley R, Harvey J . Sources of the uncertainty experienced by women with HPV. Qual Health Res. 2011; 22(4):534-45. DOI: 10.1177/1049732311424404. View

Melville J, Sniffen S, Crosby R, Salazar L, Whittington W, Dithmer-Schreck D . Psychosocial impact of serological diagnosis of herpes simplex virus type 2: a qualitative assessment. Sex Transm Infect. 2003; 79(4):280-5. PMC: 1744709. DOI: 10.1136/sti.79.4.280. View

Chrysostomou A, Stylianou D, Constantinidou A, Kostrikis L . Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing. Viruses. 2018; 10(12). PMC: 6315375. DOI: 10.3390/v10120729. View

Waller J, McCaffery K, Kitchener H, Nazroo J, Wardle J . Women's experiences of repeated HPV testing in the context of cervical cancer screening: a qualitative study. Psychooncology. 2006; 16(3):196-204. DOI: 10.1002/pon.1053. View

Bickford J, Barton S, Mandalia S . Chronic genital herpes and disclosure.... The influence of stigma. Int J STD AIDS. 2007; 18(9):589-92. DOI: 10.1258/095646207781568484. View

10.

Lin H, Jeng C, Wang L . Psychological responses of women infected with cervical human papillomavirus: a qualitative study in Taiwan. Taiwan J Obstet Gynecol. 2011; 50(2):154-8. DOI: 10.1016/j.tjog.2011.01.035. View

11.

Mills N, Daker-White G, Graham A, Campbell R . Population screening for Chlamydia trachomatis infection in the UK: a qualitative study of the experiences of those screened. Fam Pract. 2006; 23(5):550-7. DOI: 10.1093/fampra/cml031. View

12.

Perrin K, Daley E, Naoom S, Packing-Ebuen J, Rayko H, McFarlane M . Women's reactions to HPV diagnosis: insights from in-depth interviews. Women Health. 2006; 43(2):93-110. DOI: 10.1300/J013v43n02_06. View

13.

Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A . Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol. 2010; 11(3):249-57. DOI: 10.1016/S1470-2045(09)70360-2. View

14.

McCaffery K, Irwig L . Australian women's needs and preferences for information about human papillomavirus in cervical screening. J Med Screen. 2005; 12(3):134-41. DOI: 10.1258/0969141054855238. View

15.

McCaffery K, Waller J, Forrest S, Cadman L, Szarewski A, Wardle J . Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact. BJOG. 2005; 111(12):1437-43. DOI: 10.1111/j.1471-0528.2004.00279.x. View

16.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

17.

Jeynes C, Chung M, Challenor R . 'Shame on you'--the psychosocial impact of genital warts. Int J STD AIDS. 2009; 20(8):557-60. DOI: 10.1258/ijsa.2008.008412. View

18.

Thomas J, Harden A . Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol. 2008; 8:45. PMC: 2478656. DOI: 10.1186/1471-2288-8-45. View

19.

Duncan B, Hart G, Scoular A, Bigrigg A . Qualitative analysis of psychosocial impact of diagnosis of Chlamydia trachomatis: implications for screening. BMJ. 2001; 322(7280):195-9. PMC: 26583. DOI: 10.1136/bmj.322.7280.195. View

20.

Marlow L, Zimet G, McCaffery K, Ostini R, Waller J . Knowledge of human papillomavirus (HPV) and HPV vaccination: an international comparison. Vaccine. 2012; 31(5):763-9. DOI: 10.1016/j.vaccine.2012.11.083. View